SEP 25, 2015 3:07 PM PDT

Immunity by Manipulating Genes

WRITTEN BY: Ilene Schneider
Scientists remove mechanism that lets pathogens cause disease.To protect people from infectious disease, clinicians can target pathogens and parasites with medicines such as antibiotics, or scientists can manipulate the conditions that enable transmission. Researchers from the University of Virginia School of Medicine and the University of Colorado have demonstrated the effectiveness of a third strategy: changing the landscape of the human body to remove the mechanism that enables pathogens to cause disease. Their findings were reported in Drug Discovery & Development.
 
The scientists have silenced genes within human cells to induce immunity to the parasite E. histolytica, which infects 50 million people and causes 40,000 to 110,000 deaths worldwide annually by means of severe diarrhea. According to the University of Virginia’s Chelsea Marie, a research scientist in infectious diseases and international health, noting the challenge the researchers faced in blocking the amoeba’s ability to kill human cells, “This amoeba is a cluster bomb – a voracious killer. In the back of my mind, I was thinking the parasite was going to decimate the host cells no matter what we did with their genetics.”
 
Using a technique called RNAi to create a library of bladder cancer cells with thousands of independent, silenced genes, the researchers challenged these cultures with E. histolytica. According to Dr. Dan Theodorescu, formerly of the University of Virginia and now director of the University of Colorado Cancer Center, “We do this all the time in cancer research. Commonly, we’re looking for genes that, when silenced, will make cells more susceptible to chemotherapy.”
 
In this research, the analog of chemotherapy was the infectious, dangerous pathogen. E. histolytica decimated thousands of the manipulated cell cultures, but a small number of cells resisted the parasite.
 
To find out whether this was chance or a case of silenced resisting immunity, Marie discarded the dead cells and retested the survivors. She again infected the cells with E. histolytica, reporting, “It wasn’t a fluke. We did this over nine generations of cells, each time selecting the cells that survived and then re-applying the parasite. Over these generations of selection, we saw the cultures becoming more and more enriched for cells lacking specific genes.”
 
Marie identified the genes that conferred resistance using next-generation sequencing and discovered that many were involved in managing the flow of potassium into and out of human cells. A follow-up experiment revealed that, when unimpeded, E. histolytica caused intestinal cells to pump out potassium directly before cell death.
 
Theodorescu said, “We started to see a pretty clear line of reasoning. The parasite was causing potassium efflux right before cell death, and cells that happened to be unable to transport potassium didn’t die.”
 
According to Dr. William A. Petri Jr., chief of the University of Virginia’s Division of Infectious Diseases and International Health, “There is a clear need for new drugs targeting E. histolytica. Right now there is a single antibiotic that works against this parasite. We know that eventually the parasite will develop resistance to the antibiotic, and at that point there’s no plan B. This could be the plan B – targeting the human genes that enable the parasite to cause disease.”
 
Theodorescu concluded, “This is a major finding with translational implications for this infection that causes so many deaths worldwide, but also proof that this cancer-science approach can be used to explore genetic mechanisms of resistance in the field of infectious disease.”
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAR 27, 2020
Genetics & Genomics
MAR 27, 2020
Expanding the Genomic Regions That Can Be Targeted With CRISPR
CRISPR gene-editing technology has sparked a revolution in biomedical research and is poised to have far-reaching applic ...
APR 03, 2020
Genetics & Genomics
APR 03, 2020
Physical Forces Can Change How Genes Are Expressed
Less than a millisecond after a cell is stretched out, genes are activated, which will result in the production of prote ...
APR 12, 2020
Genetics & Genomics
APR 12, 2020
Even Brief Exposure to Air Pollution Can Affect Gene Expression
Studies in mice and humans have shown that the negative health effects of pollution are accompanied by changes in gene e ...
MAY 06, 2020
Cardiology
MAY 06, 2020
Can Alcohol Consumption Increase Your Risk of Peripheral Arterial Disease?
Peripheral Arterial Disease (PAD) is a chronic disease where plaque builds up in the arteries in the legs. This buildup ...
MAY 09, 2020
Clinical & Molecular DX
MAY 09, 2020
Rapid, Efficient COVID-19 Diagnostic Method Relies on Magnetic Beads
The pandemic virus SARS-CoV-2 has spread widely, and a lack of testing has been a serious problem.
MAY 25, 2020
Genetics & Genomics
MAY 25, 2020
FDA Approves the First Treatment for Neurofibromatosis 1
In a major breakthrough, the Food and Drug Administration has approved a treatment for a genetic disorder called neurofi ...
Loading Comments...